Monday, 28 May 2018

You are here

The RheumNow Week in Review - 23 February 2018

Dr Jack Cush reviews highlights from the past week on RheumNow.com. This week’s video is in two parts; for part Ii, go to https://buff.ly/2BM9MjL

  1. Duke Federico of Montefeltro (1422-1482) shown to have #gout based on letters and examination of skeletal remains. Gout was alive and active during the Italian Renaissance. https://t.co/yNnYWZlU5G
  2. Gout management by UK Rheums conform to guidelines, yet ~45% reach target SUA<6.0.  Study of 4343 Gout pts; 82% M; 13% crystal-proven. 29% stopped diuretic, 76% on ULT; prophylaxis was co-prescribed for 94%. https://buff.ly/2F0yLlA
  3. FDA grants "breakthrough" status to Pfizers Xeljanz (tofacitinib) for phase III trials in atopic dermatitis https://t.co/hzdMTjxmg1
  4. Dr. Hyman Zimmerman is famous for drug-induced hepatocellular injury plus jaundice conferring a 10% mortality rate. "Hy's Law" is used by the FDA to judge serious hepatotoxicity and risk of death; Requires evidence of jaundice and ALT/AST >3x ULN https://t.co/qu65fdGscf
  5. Australian study shows ACL injuries in children  have increased 148% in 10 yrs (2.74 per 100,000 2005 to 6.79 per 100,000 in 2015). US pediatricians have also reported increases in ACL tears in children/teens. https://t.co/Z5m2vQvlEk
  6. PANTS study: Personalized anti-TNF Therapy in Crohn Disease tests real-world eficacy, safety & immunogenicity of infliximab vs biosimilar CT- P13 vs adalimumab. Wk 54 remission rate was 40% INFX, 40% CTP13 & 34% in ADA; immunogenicity was 26%, 28%, 11% https://t.co/irhImH6ipP
  7. 3 decade study from Mayo clinic shows the incidence of symptomatic and asymptomatic renal stones increased 14-29% per 5 years in men and women https://t.co/yMmsQkxxHx
  8. Dentists are ill at ease providing dental surgery to patients on bisphosphonates. 63% active ask about BP Rx, 85% reluctant to do dental surgery if on BP Rx. https://t.co/pkmuvKGMT3
  9. Oral Anticoagulation Effective Following Hip and Knee Replacement Surgery  
  10. Are ANA Tests Unreliable 
  11. Pediatric Use of TNF inhbitors Does Not Increase Malignancy Risk  
  12. HERO Trial - Hydroxychloroquine Fails in Hand Osteoarthritis 
  13. Apremilast Continues to Look Good in Behcet's Disease 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review – Methotrexate CIRT Study (5.25.18)

Dr. Jack Cush reviews this past week's news from RheumNow.com - the risk of Cutaneous and Systemic LE, increasing flu vaccination, higher risk of VTE, MPO predictions, new drug for GIOP and CIRT - MTX in cardiovascular risk patients.

ACR Leaders Lobby Capitol Hill for Help on Rising Costs and Access Barriers in Arthritis Care

Rheumatologists and rheumatology health professionals convened on Capitol Hill this week to urge legislative action on pressing policy issues affecting rheumatology care during the American College of Rheumatology’s Advocacy Leadership Conference, held May 16 -17, 2018 in Washington, D.C.

The RheumNow Week in Review – Modifiable Behavior (5.18.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  He discusses opioids, new approval for polyarticular JIA, running and osteoarthritis, and modifiable behaviors that influence outcomes. 

The RheumNow Week in Review - Nonadherence and Astronomic Costs (5.11.18)

Dr. Jack Cush reviews highlights, news and journal articles from the past week on RheumNow.com.

Rising Need for Weight Loss Counseling in Arthritic Patients

The CDC's May 4th MMWR reports that from 2002 to 2014, the prevalence of health care provider counseling for weight loss among adults with arthritis and overweight or obesity increased by 10% (from 35% to 45%).

Among the 54.4 million adults with doctor-diagnosed arthritis in the United States, 32.7% are overweight and 38.1% are obese. Moreover obesity is more prevalent among persons with arthritis than among those who do not have arthritis.